United States: In Connecticut, COVID-19 cases and hospitalizations have been steadily increasing since June, sparking apprehension among individuals with compromised immune systems.
On August 28, Madeline Wilson, the Chief Campus Health Officer, released an email highlighting the rising levels of COVID-19 in wastewater across the US, with a particularly high concentration in the Northeastern states. Wastewater testing has become a vital early signal, revealing both the spread of cases and the emergence of new variants of infectious diseases like COVID-19, according to the reports by yaledailynews.com.
Akiko Iwasaki, a professor specializing in immunobiology at the School of Medicine, conveyed that the globe is currently grappling with a summer surge of COVID-19 cases originating in July. The wave has resulted in an estimated one million new cases per day in the US, accompanied by an increase in hospital admissions, with Connecticut witnessing 73,000 emergency visits related to COVID-19 in the past week.
The dominant strain of the virus in circulation, according to Iwasaki, is KP.31.1, which accounts for nearly half of the nation’s cases. She emphasized that for individuals with robust immune systems—particularly those vaccinated or with prior infection-derived immunity—this strain poses no greater threat than its preceding Omicron sub-variants.
Albert Ko, a professor of epidemiology at the School of Public Health, explained that COVID-19 is assuming a seasonal pattern, with infections peaking during winter and summer months. These peaks are driven by the emergence of variants and the increased likelihood of people gathering indoors. Ko highlighted the role of global travel in transmitting variants across borders, causing waves of infection in regions like the United States, as per the reports by yaledailynews.com.
Yet, concerns persist within the immunocompromised segment of the Yale community, especially given Yale’s decision to relax COVID-19 safety measures over recent years. In February, Yale halted data collection on positive cases, a shift that has prompted mixed reactions.
English professor Katie Trumpener, returning to in-person teaching after four years of remote instruction, expressed concern due to her immunocompromised status. Trumpener’s medical specialist maintains that the risks associated with the virus persist, even as society adapts to living with it. Nevertheless, she acknowledged the need to strive for a “partial return” to pre-pandemic normalcy.
“I worry that, like the CDC, Yale’s policies are shaped not only by sound medical guidance but also by what they believe will be widely accepted by the public,” Trumpener wrote. “This approach leads to a lack of mandatory vaccination, testing, or isolation. Furthermore, it overlooks provisions for transitioning to hybrid learning when students or faculty fall ill.”
Pericles Lewis, Dean of Yale College, conveyed that the University remains attentive to the needs of disabled or immunocompromised students. Although regular testing is no longer mandatory, efforts are being made to ensure resources and educational materials are available. Lewis also introduced the new Office of University Health, led by Wilson, tasked with disseminating information on vaccine access and other health services, though further details on this office remain scarce, as per yaledailynews.com.
Trumpener expressed gratitude for Yale’s initial decision to transition to online learning at the pandemic’s onset but lamented the lack of focus on vulnerable groups, stating, “As a society, we act as though everything is back to normal. For some of us, it’s far from normal, and we may never return to that state.”
Trumpener advocated for formal representation of immunocompromised faculty and students in decision-making processes concerning COVID-19 policies.
Ko pointed out that due to widespread vaccination and the milder severity of current infections, the prevalence of “long COVID” has also declined.
Vaccinations will be available at Yale later this month, as stated in Wilson’s email. Ko advised that receiving the vaccine ahead of the winter season is prudent for safeguarding against both infection and long-term effects. However, given the waning efficacy of the vaccine, he recommended that immunocompromised individuals receive it two to three times annually.
“If we stay current with vaccinations, it can offer protection for a few months, but many others are contracting the virus and building immunity, which drives herd immunity,” Ko told the News. “However, the vaccine’s effectiveness typically lasts less than six months,” as per yaledailynews.com.
Additionally, Iwasaki recommended Paxlovid, an oral antiviral pill, for individuals at elevated risk of severe illness due to pre-existing health conditions.
Wilson concluded her message by encouraging vaccination and supporting those who prefer to wear masks, even when not symptomatic. She reiterated that Yale regularly monitors respiratory illnesses at both the local and national levels.
“As we look forward, like many institutions, we are shifting toward managing COVID as a recurrent, endemic infection, anticipating periodic waves and adapting to live alongside them,” Wilson concluded.